IL2RA and acute myeloid leukemia: CD25, also known as the α-subunit of the interleukin-2 receptor (IL2RA), is a cell surface molecule that is abnormally expressed on LSCs in a subset of AML patients (5–7) and its expression is associated with lower survival (8).